Times are shown in your local time zone GMT
Ad-blocker Detected - Your browser has an ad-blocker enabled, please disable it to ensure your attendance is not impacted, such as CPD tracking (if relevant). For technical help, contact Support.
Sabrina Xu
Head of Novel Modalities and Investment Projects - Merck Life Science
Professional Bio
Leveraging an impressive 15-year career in the Life Science Industry, Sabrina has held key roles, most recently serving as the Head of Customer Application for Novel Modalities and Investment Projects in APAC (excluding China). Her leadership in this capacity involved steering a dynamic team to provide innovative solutions for biotech companies specializing in mRNA, pDNA, VVT, and ADC. Sabrina played a pivotal role in Merck Life Science's sustainability project, contributing to the development of strategies and tactical support for biotech companies aiming to advance sustainability initiatives.
With a rich background encompassing 6 years in single-use and integrated systems technology, Sabrina led a team dedicated to delivering optimal single-use process solutions to biopharmaceutical companies. Her focus was on reducing costs, enhancing efficiency, and ensuring high product quality for patient safety. Prior to this, Sabrina served as the Associate Director for Emerging Biotech Development in APAC, facilitating financial support for biotech companies from venture capital firms and addressing challenges across drug discovery, development, and production.
Sabrina's professional journey also includes roles such as Senior Sales Manager for Global Strategic Accounts in China and Strategy Analyst for Local Investments in China. She holds a Bachelor of Engineering degree in Pharmaceutical Engineering from the East China University of Science Technology, a Master of Science degree in Bioinformatics from Tongji University, and has successfully completed Merck’s EMMP program (Mini MBA) at Peking University."